Related Interviews

The First Half of 2019 Expected to Be Rough for the Biotech Sector
March 15, 2019
Singh, Hartaj

Managing an International High Dividend Yield Strategy
June 01, 2018
Buchwald, Richard E., Kline, Marvin I.

Biotech Space on the Cusp of Seismic Changes
April 21, 2017
Chattopadhyay, Debjit

Data is King for Development-Stage Biotech Companies
April 21, 2017
Nochomovitz, Yigal

Finding Undervalued Assets in the Biotech Sector
November 18, 2016
Adams, Douglas N.

Looking for Biopharmaceuticals with Disruptive Innovation and Medicines Initiatives
August 12, 2016
Amusa, Gbola

Clinical Advancements and Drug Launches in Therapeutics Fuel Investor Enthusiasm
August 19, 2014

Long-Term Investing with a Margin of Safety
May 22, 2014

Increased Biotech Productivity and Innovation Reflected in FDA-Approved Drugs
August 23, 2013

New Product Generation and an Easing Regulatory Environment in Biopharmaceuticals
August 05, 2013

Identifying Hidden Value and Market Opportunities in Biotech Companies
March 21, 2013

Product Pipeline & Diversification Are Key In Pharma - Dr. Jon Lecroy, M.d. - Mkm Partners
November 14, 2011

Production And Aftermarket Growth In Commercial Aerospace - Peter Skibitski - Suntrust Robinson Humphrey, Inc.
November 14, 2011

Nano Manufacturing Prospects In Semiconductors - Daniel Heyler - Bank Of America Merrill Lynch (asia Pacific) Ltd.
June 13, 2011

Internet Interactivity Trends In 2011 - Brian J. Pitz - Ubs Investment Bank
April 04, 2011

Med Tech As Health Care System Cost Reducer - Scott Gleason - Stephens Inc.
November 15, 2010

Health Care Services & Tech Outlook - Ross Muken - Deutsche Bank Securities, Inc.
November 15, 2010

Conservative & Flexible Active Portfolio Management - Sean Chaitman - Shelter Rock Management, Llc
September 20, 2010

Investing In Managed Futures - Alan C. Snyder - Shinnecock Partners
June 28, 2010

Overview Of Midwestern Regional Bank Metrics - Craig Siegenthaler - Credit Suisse
April 05, 2010

Investing In Large-cap Growth Companies - David A. Rolfe & Michael X. Quigley - Wedgewood Partners, Inc.
January 11, 2010

Value Investing In Advantaged Businesses - Larry D. Coats Jr. & Christy L. Phillips
July 27, 2009

Absolute Value Investing - Jean-luc Nouzille, David Fleer & Howard Deshong - Bristlecone Value Partners, Llc
January 29, 2007

COMMUNICATIONS EQUIPMENT: RICHARD CHURCH - C.E. UNTERBERG, TOWBIN
July 11, 2006

ROUNDTABLE FORUM: GAMING
July 10, 2006

W.MORRILL JR. / D. OLIVER - BROWN INVESTMENT ADVISORY & TRUST COMPANY
March 27, 2006

AUTOMOTIVE DEALERS: JOHN TOMLINSON - MAJESTIC RESEARCH
January 16, 2006

Deborah Miller - Ascendent
September 16, 2005

E.BARLOW / M.STEPHENSON - ALTA CAPITAL MANAGEMENT LLC
August 01, 2005

ROUNDTABLE FORUM:MID-ATLANTIC & SOUTHEAST REGIONAL BANKS
February 21, 2005

TOM HICKEY - TULLOW OIL PLC (TLW)
March 15, 2004

M.HARDY / G.SWEENEY - NORTHERN CAPITAL MANAGEMENT COMPANY
March 08, 2004

AARON DUNN - U.S. GLOBAL INVESTORS
January 26, 2004

Investment Opportunities In The Energy Supply Chain: J.smith - Gabelli Asset Management
September 01, 2003

Outlook For Eastern Banks: Gerard Cassidy - Rbc Capital Markets
August 25, 2003

L.holtz / Y.lipsker - Roger Engemann & Associates
July 28, 2003

Keith Bigsby - Tadpole Technology Plc (tad.l)
June 30, 2003

Investing In Biotechnology: Mark Monane - Needham & Co
June 02, 2003

Daniel Glassman - Bradley Pharmaceuticals Inc (bdy)
May 27, 2003

Michele Ward - Retirement System Investors Inc
April 28, 2003

Peter Ganucheau Iv - Gsb Investment Management Inc
April 28, 2003

Michael Sicuro - Lightspan Inc (lspn)
April 21, 2003

Alexander Motola - Thornburg Investment Management
April 07, 2003

Outlook For Solid Waste Companies: Thomas Ford - Lehman Brothers
October 14, 2002

Large Cap Biotechnology & Life Sciences: Ronald Renaud - Bear, Stearns & Co
September 13, 2002

David Thomas - Ims Health Inc (rx)
September 13, 2002

Arno Mayer - Steinberg Global Asset Management
August 26, 2002

Gold Stocks: Daniel Mcconvey - Goldman Sachs & Co
May 27, 2002

Jeffrey Felman - Weber Fulton & Felman Investment Counsel Llc
March 25, 2002

Drug Development & Biotechnology Companies: Ken Trbovich - C.e. Untergerg, Towbin
February 04, 2002

Pharmaceutical Industry Outlook: Jerry Treppel - Banc Of America Securities
December 05, 2001

Saks Medscience Fund: David Saks - Saks Medscience Fund
December 05, 2001

Managing Drug Costs: David Shook - Businessweek Online
December 05, 2001

Martin Stein Jr. - Regency Centers Corporation (reg)
November 28, 2001

Elliot Hahn - Andrx Corporation (adrx)
September 14, 2001

The New Biotechnology Environment: Sushant Kumar - Mehta Partners
June 07, 2001

Mark Frevert - Enron Wholesale Services (ene)
May 31, 2001

William Meyer - American Greetings Corporation (am)
February 05, 2001

Richard Parry - Tom Johnson Investment Management
January 29, 2001

Gary Holland - Fargo Electronics Inc (frgo)
January 11, 2001

Robert Cummisford - Lyon Street Asset Management Company
October 09, 2000

Carl Colombo - Highmark Capital Management
October 02, 2000

Mark Hunter - Axon Group Plc (axo.l)
September 25, 2000

Logistics Industry : Peter Coleman - Bank Of America Securities Llc
September 20, 2000

E.o. Edgerton Jr. - Capital Investment Counsel Inc
August 14, 2000

Bodo Wilkens - Energiekontor Ag (ekt.f)
August 07, 2000

Charles Gehring - Insight Capital Research & Management
April 24, 2000

Lodging & Ski Companies: Bryan Maher - Credit Lyonnais Securities Usa
April 06, 2000

John F. Ray - Legacy Asset Management
January 31, 2000

Biotechnology Stocks : Meg Malloy - Chase H&q
January 13, 2000

Media & Entertainment Stocks : Richard J. Macdonald - J.p. Morgan Securities
January 03, 2000

J. Alan Day - The Stratavest Group
December 20, 1999

Thomas K. Porta - Porta Investment Management
September 13, 1999